Meristem Family Wealth, LLC Edwards Lifesciences Corp Transaction History

Meristem Family Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $312,758 - $407,380	-3,797 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $562,513 - $708,051	-5,517 Reduced 59.23%	3,797 $447,000
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $83,048 - $99,059	807 Added 9.49%	9,314 $1.05 Million
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $163,488 - $204,282	1,950 Added 29.74%	8,507 $881,000
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $82,945 - $105,553	1,157 Added 21.43%	6,557 $598,000

Q2 2020 Aug 06, 2020	BUY	$57.54 - $76.95 $207,144 - $277,020	3,600 Added 200.0%	5,400 $373,000
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $524 - $810	-10 Reduced 0.55%	1,800 $340,000
Q3 2019 Nov 08, 2019	BUY	$61.55 - $75.43 $111,405 - $136,528	1,810 New	1,810 $398,000

1,378

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.